These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29921380)

  • 1. Different molecular subtypes of breast invasive ductal carcinoma.
    Zheng LJ; Yang D; Sun LJ; Li SS; Wang JY; Ye SC
    J Biol Regul Homeost Agents; 2018; 32(3):553-563. PubMed ID: 29921380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of IRS-1 associates with phosphorylated Akt expression and predicts poor prognosis of breast invasive ductal carcinoma.
    Luo J; Feng J; Wen Q; Qoyawayma C; Wang W; Chen L; Lu J; Zhan Y; Xu L; Zang H; Fan S; Chu S
    Hum Pathol; 2018 Sep; 79():9-17. PubMed ID: 29551677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
    Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
    Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p53 protein expression in HER2-negative breast invasive ductal carcinoma].
    Qing Z; Zou W; Luo J; Wen Q; Fan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1016-22. PubMed ID: 25355267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma.
    Guo C; Fu M; Dilimina Y; Liu S; Guo L
    Exp Ther Med; 2018 Mar; 15(3):2851-2859. PubMed ID: 29599829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
    Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ
    Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
    Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
    J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
    Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
    Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between breast cancer molecular subtypes with clinicopathological characteristics and prognosis].
    Lin M; Chen ZQ; Bao Y; Li Q; Du ZG; Xu ZD; Tang F
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):372-6. PubMed ID: 21055152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
    Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
    Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status.
    Plaza MJ; Handa P; Esserman LE
    AJR Am J Roentgenol; 2017 Apr; 208(4):910-915. PubMed ID: 28140614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.
    Wang Z; Zhou Q; Liu J; Tang S; Liang X; Zhou Z; He Y; Peng H; Xiao Y
    Int J Clin Exp Pathol; 2014; 7(10):6985-91. PubMed ID: 25400785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical profile and clinical-pathological variables in breast cancer.
    Cintra JR; Teixeira MT; Diniz RW; Gonçalves Junior H; Florentino TM; Freitas GF; Oliveira LR; Neves MT; Pereira T; Guerra MR
    Rev Assoc Med Bras (1992); 2012; 58(2):178-87. PubMed ID: 22569612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F; Simionescu C; Georgescu CV; Pirici E
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
    Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
    Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.